Search results

Articles (7)

Journals (0)

1-7 of 7 results for FDA two-study paradigm

Sort by:

Relevance

Select all

Sort by:

Relevance

Restricted accessOtherFirst published January, 1999

One Large,Well-Designed,Multicenter Study as an Alternative to the Usual FDA Paradigm

Lloyd D. Fisher

Therapeutic Innovation & Regulatory Science

Free accessResearch articleFirst published March, 2004

A Brief History of Immunotoxicology and a Review of the Pharmaceutical Guidelines

Jack H. Dean

International Journal of Toxicology

Restricted accessResearch articleFirst published 2025

Efficacy and safety of phosphoinositide 3-kinase inhibitors and AKT-inhibitors in combination with fulvestrant in PIK3CA mutated,HR-positive,HER2-negative invasive breast cancer: A systematic review

Chris Larck, Joseph B Elmes, R. Wesley Haynes [...]

Journal of Oncology Pharmacy Practice

Restricted accessResearch articleFirst published August, 2018

The inadequacy of the reductionist approach in discovering new therapeutic agents against complex diseases

Manuel X Duval

Experimental Biology and Medicine

Open accessArticle commentaryFirst published 2026

Blockade of Corticotropin-Releasing Hormone Receptor 1 Receptors in the Arcuate Nucleus May Effectively Treat Infantile Epileptic Spasms Syndrome

Jeffrey H. Goodman

Epilepsy Currents

Restricted accessResearch articleFirst published November, 2015

Reconceptualizing Consent for Direct-to-Consumer Health Services

Kayte Spector-Bagdady

American Journal of Law & Medicine

Restricted accessResearch articleFirst published August, 2001

Engineered antibodies take center stage

James S. Huston, Andrew J.T. George

Human Antibodies

Search results

Articles (7)

Journals (0)

1-7 of 7 results for FDA two-study paradigm

Sort by:

Relevance

Select all

Sort by:

Relevance

Restricted accessOtherFirst published January, 1999

One Large,Well-Designed,Multicenter Study as an Alternative to the Usual FDA Paradigm

Lloyd D. Fisher

Therapeutic Innovation & Regulatory Science

Free accessResearch articleFirst published March, 2004

A Brief History of Immunotoxicology and a Review of the Pharmaceutical Guidelines

Jack H. Dean

International Journal of Toxicology

Restricted accessResearch articleFirst published 2025

Efficacy and safety of phosphoinositide 3-kinase inhibitors and AKT-inhibitors in combination with fulvestrant in PIK3CA mutated,HR-positive,HER2-negative invasive breast cancer: A systematic review

Chris Larck, Joseph B Elmes, R. Wesley Haynes [...]

Journal of Oncology Pharmacy Practice

Restricted accessResearch articleFirst published August, 2018

The inadequacy of the reductionist approach in discovering new therapeutic agents against complex diseases

Manuel X Duval

Experimental Biology and Medicine

Open accessArticle commentaryFirst published 2026

Blockade of Corticotropin-Releasing Hormone Receptor 1 Receptors in the Arcuate Nucleus May Effectively Treat Infantile Epileptic Spasms Syndrome

Jeffrey H. Goodman

Epilepsy Currents

Restricted accessResearch articleFirst published November, 2015

Reconceptualizing Consent for Direct-to-Consumer Health Services

Kayte Spector-Bagdady

American Journal of Law & Medicine

Restricted accessResearch articleFirst published August, 2001

Engineered antibodies take center stage

James S. Huston, Andrew J.T. George

Human Antibodies